Tsifansky MD - Search Results

1

Succinylated chitosan derivative has local protective effects on intestinal inflammation.

Hyun H, Hashimoto-Hill S, Kim M, Tsifansky MD, Kim CH, Yeo Y. Hyun H, et al. Among authors: tsifansky md. ACS Biomater Sci Eng. 2017;3(8):1853-1860. doi: 10.1021/acsbiomaterials.7b00262. Epub 2017 Jun 5. ACS Biomater Sci Eng. 2017. PMID: 29450257 Free PMC article.

2

Zwitterionic chitosan for the systemic treatment of sepsis.

Cho EJ, Doh KO, Park J, Hyun H, Wilson EM, Snyder PW, Tsifansky MD, Yeo Y. Cho EJ, et al. Among authors: tsifansky md. Sci Rep. 2016 Jul 14;6:29739. doi: 10.1038/srep29739. Sci Rep. 2016. PMID: 27412050 Free PMC article.

3

Development of highly porous large PLGA microparticles for pulmonary drug delivery.

Yang Y, Bajaj N, Xu P, Ohn K, Tsifansky MD, Yeo Y. Yang Y, et al. Among authors: tsifansky md. Biomaterials. 2009 Apr;30(10):1947-53. doi: 10.1016/j.biomaterials.2008.12.044. Epub 2009 Jan 8. Biomaterials. 2009. PMID: 19135245

4

Recent advances in nanomedicine for sepsis treatment.

Yuk SA, Sanchez-Rodriguez DA, Tsifansky MD, Yeo Y. Yuk SA, et al. Among authors: tsifansky md. Ther Deliv. 2018 May 1;9(6):435-450. doi: 10.4155/tde-2018-0009. Ther Deliv. 2018. PMID: 29722636 Free PMC article. Review.

5

Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.

Ibrahim BM, Tsifansky MD, Yang Y, Yeo Y. Ibrahim BM, et al. Among authors: tsifansky md. Expert Opin Drug Deliv. 2011 Apr;8(4):451-66. doi: 10.1517/17425247.2011.561310. Epub 2011 Mar 5. Expert Opin Drug Deliv. 2011. PMID: 21375469 Review.

6

Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis.

Yuk SA, Kim H, Abutaleb NS, Dieterly AM, Taha MS, Tsifansky MD, Lyle LT, Seleem MN, Yeo Y. Yuk SA, et al. Among authors: tsifansky md. Sci Adv. 2021 Aug 6;7(32):eabj1577. doi: 10.1126/sciadv.abj1577. Print 2021 Aug. Sci Adv. 2021. PMID: 34362742 Free PMC article.

7

Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis.

Yang Y, Tsifansky MD, Wu CJ, Yang HI, Schmidt G, Yeo Y. Yang Y, et al. Among authors: tsifansky md. Pharm Res. 2010 Jan;27(1):151-60. doi: 10.1007/s11095-009-9991-2. Epub 2009 Oct 22. Pharm Res. 2010. PMID: 19847626

8

Mannitol-guided delivery of Ciprofloxacin in artificial cystic fibrosis mucus model.

Yang Y, Tsifansky MD, Shin S, Lin Q, Yeo Y. Yang Y, et al. Among authors: tsifansky md. Biotechnol Bioeng. 2011 Jun;108(6):1441-9. doi: 10.1002/bit.23046. Epub 2011 Jan 15. Biotechnol Bioeng. 2011. PMID: 21488050

9

Microparticles for inhalational delivery of antipseudomonal antibiotics.

Tsifansky MD, Yeo Y, Evgenov OV, Bellas E, Benjamin J, Kohane DS. Tsifansky MD, et al. AAPS J. 2008 Jun;10(2):254-60. doi: 10.1208/s12248-008-9033-8. Epub 2008 May 3. AAPS J. 2008. PMID: 18454321 Free PMC article.

10

V/Q-SPECT Scintigraphy in Pulmonary Hypertension: Predictor of Mortality Versus Trigger for Transplant, A British Versus American Perspective.

Ovadia M, Tsifansky MD. Ovadia M, et al. Among authors: tsifansky md. JACC Cardiovasc Imaging. 2018 Oct;11(10):1494-1498. doi: 10.1016/j.jcmg.2017.08.028. JACC Cardiovasc Imaging. 2018. PMID: 30286909 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page